Ocugen Inc. (OCGN): Price and Financial Metrics

Ocugen Inc. (OCGN): $0.75

0.02 (+2.65%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add OCGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#292 of 306

in industry

OCGN Price/Volume Stats

Current price $0.75 52-week high $2.06
Prev. close $0.73 52-week low $0.52
Day low $0.69 Volume 2,673,581
Day high $0.75 Avg. volume 4,003,570
50-day MA $0.65 Dividend yield N/A
200-day MA $0.93 Market Cap 218.20M

OCGN Stock Price Chart Interactive Chart >


Ocugen Inc. (OCGN) Company Bio


Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of transformative therapies to cure blindness diseases. The company's pipeline product includes OCU200, a novel fusion protein that is in preclinical development stage for the treatment of wet AMD, diabetic retinopathy, and diabetic macular edema; OCU400 to treat retinitis pigmentosa, a group of rare genetic disorders; and OCU410, which is in preclinical development stage for the treatment of dry AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing. The company is headquartered in Malvern, Pennsylvania.


OCGN Latest News Stream


Event/Time News Detail
Loading, please wait...

OCGN Latest Social Stream


Loading social stream, please wait...

View Full OCGN Social Stream

OCGN Price Returns

1-mo 6.19%
3-mo -2.50%
6-mo -20.99%
1-year -43.18%
3-year -65.75%
5-year 123.21%
YTD -6.83%
2024 40.00%
2023 -55.77%
2022 -71.43%
2021 148.63%
2020 251.92%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!